US Direct-To-Consumer Laboratory Testing Market Size to Hit USD 2.92 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Direct-to-Consumer Laboratory Testing Market

5.1. COVID-19 Landscape: Direct-to-Consumer Laboratory Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. US Direct-to-Consumer Laboratory Testing Market, By Product

8.1. US Direct-to-Consumer Laboratory Testing Market, by Product

8.1.1 Medical Genetic Laboratory Testing

8.1.1.1. Market Revenue and Forecast

8.1.2. Routine Clinical Laboratory Testing

8.1.2.1. Market Revenue and Forecast

Chapter 9. US Direct-to-Consumer Laboratory Testing Market, By Test Type

9.1. US Direct-to-Consumer Laboratory Testing Market, by Test Type

9.1.1. Genetic Testing

9.1.1.1. Market Revenue and Forecast

9.1.2. COVID-19

9.1.2.1. Market Revenue and Forecast

9.1.3. Cancer

9.1.3.1. Market Revenue and Forecast

9.1.4. Diabetes Testing

9.1.4.1. Market Revenue and Forecast

9.1.5. Disease Risk Assessment Testing

9.1.5.1. Market Revenue and Forecast

9.1.6. Sexually Transmitted Disease Testing

9.1.6.1. Market Revenue and Forecast

9.1.7. Routine Testing

9.1.7.1. Market Revenue and Forecast

9.1.8. Complete Blood Count

9.1.8.1. Market Revenue and Forecast

9.1.9. Complete Blood Count

9.1.9.1. Market Revenue and Forecast

9.1.10. Thyroid Stimulating Hormone Testing

9.1.10.1. Market Revenue and Forecast

9.1.11. Other

9.1.11.1. Market Revenue and Forecast

Chapter 10. US Direct-to-Consumer Laboratory Testing Market, By Sample Type

10.1. US Direct-to-Consumer Laboratory Testing Market, by Sample Type

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast

10.1.2. Urine

10.1.2.1. Market Revenue and Forecast

10.1.3. Saliva

10.1.3.1. Market Revenue and Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Forecast

Chapter 11. US Direct-to-Consumer Laboratory Testing Market, Regional Estimates and Trend Forecast

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product

11.1.4.2. Market Revenue and Forecast, by Test Type

11.1.4.3. Market Revenue and Forecast, by Sample Type

Chapter 12. Company Profiles

12.1. 23andMe, Inc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Ambry Genetics Corp.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Ancestry.com LLC

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Any Lab Test Now, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Color Genomics, Inc

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Counsyl, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. DanteLabs Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Direct Laboratory Services, LLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Eastern Biotech & Life Sciences

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. EasyDNA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The US direct-to-consumer laboratory testing market size is expected to increase from USD 1.23 billion in 2025 to USD 2.92 billion by 2035.

Answer : The US direct-to-consumer laboratory testing market is expected to grow at a compound annual growth rate (CAGR) of around 9.03% from 2026 to 2035.

Answer : The major players in the US direct-to-consumer laboratory testing market include OME Care, Natera, Inc., Myriad Genetics, Inc., MyMedLab, Inc., Laboratory Corporation of America Holdings, Home Access Health Corporation, HealthCheckUSA, Gene by Gene, Ltd., Full Genomes Corporation, Inc., EverlyWell, Inc., Direct Laboratory Services, LLC, DanteLabs Inc., Counsyl, Inc., Color Genomics, Inc., Any Lab Test Now, Inc., Ancestry.com LLC, Ambry Genetics Corp., and 23andMe, Inc.

Answer : The driving factors of the US direct-to-consumer laboratory testing market are the rising demand for preventive healthcare, personalized diagnostics, at-home testing solutions, and increasing adoption of digital laboratory platforms.